Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-06 Sale | 2022-10-07 4:05 pm | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 29,899 | $25.9 | $774,411 | 32,000 (Direct) | View |
| 2022-09-30 Sale | 2022-10-04 5:49 pm | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 4,101 | $25.06 | $102,777 | 32,000 (Direct) | View |
| 2019-12-09 Sale | 2019-12-11 5:01 pm | Urovant Sciences Ltd. | UROV | Katkin Keith PEO;CEO/Urovant Sciences, Inc. | 120,000 | $12.78 | $1,533,600 | 881,254 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-07 Option Award | 2024-02-09 4:04 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 17,000 | $0 | 65,000 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 7:05 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Katkin Keith Director | 33,847 | $0 | 42,442 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:45 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director | 752,185 | $0 | 752,185 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 4:52 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 16,000 | $0 | 48,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 6:04 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-10-06 Exercise | 2022-10-07 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 20,782 | $7.88 | 32,000 (Direct) | View |
| 2022-10-06 Exercise | 2022-10-07 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 9,117 | $8.93 | 32,000 (Direct) | View |
| 2022-10-06 Exercise | 2022-10-07 4:05 pm | N/A 2028-05-23 | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 29,899 | $0 | 32,000 (Direct) | View |
| 2022-09-30 Exercise | 2022-10-04 5:49 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 3,218 | $7.88 | 32,000 (Direct) | View |
| 2022-09-30 Exercise | 2022-10-04 5:49 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 883 | $8.93 | 32,000 (Direct) | View |
| 2022-09-30 Exercise | 2022-10-04 5:49 pm | N/A 2028-05-23 | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 4,101 | $0 | 32,000 (Direct) | View |
| 2022-04-02 Option Award | 2022-04-05 4:22 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Katkin Keith Director | 8,595 | $0 | 8,595 (Direct) | View |
Ownership | 2022-04-05 4:18 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Katkin Keith Director | 0 | $0 | 0 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 5:30 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 16,000 | $0 | 32,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:30 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-21 8:57 pm | N/A 2031-05-19 | RIGEL PHARMACEUTICALS INC | RIGL | Katkin Keith Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:18 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2020-09-11 Option Award | 2020-09-15 8:10 pm | N/A 2030-09-11 | Novus Therapeutics Inc. | NVUS | Katkin Keith Director | 5,907 | $0 | 5,907 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-15 8:55 pm | N/A 2030-05-15 | RIGEL PHARMACEUTICALS INC | RIGL | Katkin Keith Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 6:42 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Katkin Keith PEO;CEO/Urovant Sciences, Inc. | 180,000 | $3.86 | 976,146 (Direct) | View |
| 2020-02-19 Tax Withholding | 2020-02-21 6:42 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Katkin Keith PEO;CEO/Urovant Sciences, Inc. | 104,788 | $13.08 | 976,146 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-21 6:42 pm | N/A 2027-09-21 | Urovant Sciences Ltd. | UROV | Katkin Keith PEO;CEO/Urovant Sciences, Inc. | 180,000 | $0 | 976,146 (Direct) | View |
| 2020-02-19 Other | 2020-02-21 6:42 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Katkin Keith PEO;CEO/Urovant Sciences, Inc. | 75,212 | $13.08 | 976,146 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 4:35 pm | 2021-02-12 2030-02-12 | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-09 4:33 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Katkin Keith PEO;CEO/Urovant Sciences, Inc. | 199,680 | $0 | 199,680 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 5:01 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Katkin Keith PEO;CEO/Urovant Sciences, Inc. | 120,000 | $3.86 | 881,254 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 5:01 pm | N/A 2027-09-21 | Urovant Sciences Ltd. | UROV | Katkin Keith PEO;CEO/Urovant Sciences, Inc. | 120,000 | $0 | 881,254 (Direct) | View |
| 2019-07-11 Option Award | 2019-07-15 4:05 pm | 2020-07-11 2029-07-11 | Novus Therapeutics Inc. | NVUS | Katkin Keith Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-06-10 Option Award | 2019-06-12 09:00 am | 2020-06-10 2029-06-10 | Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-24 5:23 pm | N/A 2029-05-23 | RIGEL PHARMACEUTICALS INC | RIGL | Katkin Keith Director | 55,000 | $0 | 55,000 (Direct) | View |